[1] Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in china, 1990-2010; a longitudinal analysis of national survey data. Lancet, 2014,383(9934):2057-2064.
[2] World Health Organization. Global tuberculosis report 2016. Geneva: World Health Organization,2016.
[3] Lin HH, Wang L, Zhang H, et al. Tuberculosis control in china: Use of modelling to develop targets and policies. Bull World Health Organ,2015,93(11):790-798.
[4] Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in san francisco. A population-based study using conventional and molecular methods. N Engl J Med,1994,330(24):1703-1709.
[5] Barnes PF, Cave MD. Molecular epidemiology of tuberculosis. N Engl J Med,2003,349(12):1149-1156.
[6] Glynn JR, Vynnycky E, Fine PE. Influence of sampling on estimates of clustering and recent transmission of mycobacterium tuberculosis derived from DNA fingerprinting techniques. Am J Epidemiol,1999,149(4):366-371.
[7] Yang C, Shen X, Peng Y, et al. Transmission of mycobacterium tuberculosis in china: A population-based molecular epidemiologic study. Clin Infect Dis,2015,61(2):219-227.
[8] Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in new york city. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med,1994,330(24):1710-1716.
[9] Clark CM, Driver CR, Munsiff SS, et al. Universal genotyping in tuberculosis control program, new york city, 2001-2003. Emerg Infect Dis,2006,12(5):719-724.
[10] Glynn JR, Crampin AC, Yates MD, et al. The importance of recent infection with mycobacterium tuberculosis in an area with high hiv prevalence: A long-term molecular epidemiological study in northern malawi. J Infect Dis,2005,192(3):480-487.
[11] Kato-Maeda M, Small PM. How molecular epidemiology has changed what we know about tuberculosis. West J Med,2000,172(4):256-259.
[12] 胡屹,蒋伟利,赵琦,等. 多种基因分型技术在识别结核分枝杆菌基因型的联合应用. 中华结核和呼吸杂志, 2009,32(8):576-580.
[13] Hu Y, Mathema B, Zhao Q, et al. Acquisition of second-line drug resistance and extensive drug resistance during recent transmission of Mycobacterium tuberculosis in rural china. Clin microbiol infect,2015,21(12):1093.
[14] Wang W, Mathema B, Hu Y, et al. Role of casual contacts in the recent transmission of tuberculosis in settings with high disease burden. Clin Microbiol Infect,2014,20(12):1140-1145.
[15] Lu W, Lu B, Liu Q, et al. Genotypes of Mycobacterium tuberculosis isolates in rural china: Using miru-vntr and spoligotyping methods. Scand J Infect Dis,2014,46(2):98-106.
[16] 廖培军,邱勇,郭明成,等. 四川省武胜县农村地区主动发现结核病患者调查分析.中国防痨杂志,2016,38(7):576-581.
[17] Shen G, Xue Z, Shen X, et al. The study recurrent tuberculosis and exogenous reinfection, shanghai, China. Emerg Infect Dis,2006,12(11):1776-1778.
[18] Shen X, Yang C, Wu J, et al. Recurrent tuberculosis in an urban area in china: Relapse or exogenous reinfection? Tuberculosis(Edinb),2017,103:97-104.
[19] Li X, Zhang Y, Shen X,et al. Transmission of drug-resistant tuberculosis among treated patients in shanghai, China. J Infec Dis, 2007,195(6):864-869.
[20] Nsofor CA, Jiang Q, Wu J, et al. Transmission is a Noticeable Cause of Resistance Among Treated Tuberculosis Patients in Shanghai, China. Sci Rep, 2017, 7(1):7691.
[21] World Health Organization. Global tuberculosis report 2015. Geneva: World Health Organization ,2015.
[22] 刘二勇,周林,成君,等. 健康检查与被动就诊在肺结核患者发现中的对比研究. 中国防痨杂志, 2014, 36(5):327-330.
[23] Andrew AS,GolubJE, Dowdy DW. How much is tuberculosis screening worth? Estimating the value of active case finding for tuberculosis in south africa, china, and india. BMC Med ,2014,12:216.
[24] 洪建军,沈红英,金晓萍,等. 集中推荐肺结核发现方法的研究. 上海预防医学,2004,16(6):264-265.
[25] World Health Organization. Global tuberculosis report 2013. Geneva: World Health Organization ,2013.
[26] Datta S, Shah L, Gilman RH, et al. Comparison of sputum collection methods for tuberculosis diagnosis: A systematic review and pairwise and network meta-analysis. Lancet Glob Health, 2017,5(8):e760-e771.
[27] Andrews RH Devadatta S, FoxW, et al. Prevalence of tuberculosis among close family contacts of tuberculous patients in south india, and influence of segregation of the patient on early attack rate. Bull World Health Organ,1960,23:463-510.
[28] Riley RL, Moodie AS. Infectivity of patients with pulmonary tuberculosis in inner city homes. Am Rev Respir Dis,1974, 110(6):810-812.
[29] Gunnels JJ, Bates JH, Swindoll H. Infectivity of sputum-positive tuberculous patients on chemotherapy. Am Rev Respir Dis,1974,109(3):323-330.
[30] Rouillon A, Perdrizet S, Parrot R. Transmission of tubercle bacilli: The effects of chemotherapy. Tubercle ,1976,57(4):275-299.
[31] Dharmadhikari AS, Mphahlele M, Venter K, et al. Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis, 2014 ,18(9):1019-1025.
[32] He G, Van den Hof S, Van der Werf MJ, et al. Inappropriate tuberculosis treatment regimens in chinese tuberculosis hospitals. Clin Infect Dis,2011,52(7):e153-156.
[33] Madhi SA, Nachman S, Violari A, et al. Primary isoniazid prophylaxis against tuberculosis in hiv-exposed children. N Engl J Med,2011,365(1):21-31.
[34] Martinson NA, Barnes GL, Moulton LH, et al. New regimens to prevent tuberculosis in adults with hiv infection. N Engl J Med,2011,365(1):11-20. |